Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 145,548 | 200,695 | 161,536 | 178,771 | 105,579 |
| Marketable Securities | 174,177 | 133,012 | 31,789 | 24,991 | 45,086 |
| TOTAL | $328,249 | $344,720 | $203,973 | $211,355 | $157,804 |
| Non-Current Assets | |||||
| PPE Net | 2,672 | 2,825 | 2,903 | 3,005 | 3,094 |
| Investments And Advances | 0 | 1,010 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,365 | 2,460 | 2,483 | 2,569 | 2,652 |
| TOTAL | $5,037 | $6,295 | $5,386 | $5,574 | $5,746 |
| Total Assets | $333,286 | $351,015 | $209,359 | $216,929 | $163,550 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,134 | 8,468 | 6,153 | 7,145 | 6,213 |
| Accrued Expenses | 4,452 | 6,588 | 5,375 | 3,888 | 3,191 |
| Other current liabilities | 965 | 939 | 912 | 886 | 860 |
| TOTAL | $20,257 | $15,995 | $12,440 | $11,919 | $10,264 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,706 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,822 | 3,076 | 3,329 | 3,570 | 3,806 |
| TOTAL | $9,985 | $3,076 | $3,329 | $3,570 | $3,806 |
| Total Liabilities | $30,242 | $19,071 | $15,769 | $15,489 | $14,070 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,506 | 47,785 | 47,500 | 38,564 | 37,593 |
| Common Shares | 615,118 | 607,581 | 438,063 | 418,040 | 339,976 |
| Retained earnings | -309,882 | -275,255 | -244,461 | -216,610 | -190,515 |
| Other shareholders' equity | -2,192 | -382 | -12 | 10 | 19 |
| TOTAL | $303,044 | $331,944 | $193,590 | $201,440 | $149,480 |
| Total Liabilities And Equity | $333,286 | $351,015 | $209,359 | $216,929 | $163,550 |